Announcing the 2022 Women’s Health Equity Fellow at the Penny Anderson Women’s Cardiovascular Center

Sep 19, 2022
Image
Delaine

The Penny Anderson Women’s Cardiovascular Center at the Minneapolis Heart Institute Foundation® (MHIF) is committed to closing the gap and eliminating disparities that exist in health care delivery and outcomes between men and women and for people of color. As part of the educational aim for the center, a one-year fellowship in women’s health equity has been created and we are thrilled to announce that Delaine Teabout Thomas, MPH has been selected to serve as its first-ever fellow.

Delaine comes with previous MHIF experience, having worked as the Population Health Intern in 2021, where she was instrumental in helping to building community partnerships and host community conversations and events.

Delaine’s passion for women’s health equity was sparked by personal experiences navigating the health care system and her own wellness journey. To better understand how to serve community, Delaine earned her Bachelor of Science in Public Health from The Ohio State University with a dual focus on Policy and Maternal Child Health. This May, Delaine completed her Master of Public Health in Administration & Policy, with her primary research examining if and how health-related organizations in Minnesota acted on health equity and anti-racism commitments made after the murder of George Floyd.

Give the Gift of Hope
4 photos of families smiling

The Minneapolis Heart Institute Foundation® (MHIF) strives to create a world without heart and vascular disease. To achieve this bold vision, we are dedicated to improving the cardiovascular health of individuals and communities through innovative research and education.

Thanks to the generosity of donors like you, we can continue this life-saving work. Please make a gift to support the area of greatest need.

Research Milestone: FDA approves device used as alternative to open-heart

blue background
Triclip team

We are honored to celebrate the culmination of years of research that has resulted in new technologies for patients! In the few last weeks, we announced a similar research milestone with the FDA approval of the TriClip system for tricuspid regurgitation. We celebrated this important milestone with local media KSTP-TV, who spotlighted the importance of this new technology. We were proud to be a leading clinical site led by Global PI Dr. Paul Sorajja and the MHIF research team who contributed significant data to the pivotal trial.